ClinicalTrials.Veeva

Menu

GLP-1: Acute Effects on Kidney Function in Healthy Men

J

Jeppe Skov

Status

Completed

Conditions

Kidney Functional

Treatments

Biological: Human GLP-1 (7-36) amide
Biological: Isotone NaCl

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT01333163
VEKRM 29414

Details and patient eligibility

About

The purpose of this study is to investigate how Glucagon-Like Peptide 1 (GLP-1) affects kidney function in healthy young men. The hypothesis is that GLP-1 induces a positive effect on kidney hemodynamics.

Enrollment

12 patients

Sex

Male

Ages

18 to 30 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Healthy young men

Exclusion criteria

  • Any chronic diseases

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

12 participants in 2 patient groups, including a placebo group

GLP-1
Active Comparator group
Treatment:
Biological: Human GLP-1 (7-36) amide
Placebo
Placebo Comparator group
Treatment:
Biological: Isotone NaCl

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems